Recently, higher levels of Glial Fibrillary Acid Protein (GFAP) and Neurofilament Light chain (NfL) in the serum of FTD and AD patients compared to healthy controls were reported [39,40,41,42]. The gene discussed is GFAP; the disease is Alzheimer disease.